Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-002816-25Phase 3Completed
Phase 3, randomised, double-blind trial of beclomethasone dipropionate and salbutamol in asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Mean morning peak expiratory flow. Started Jul 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-002816-25.